Monsanto Company (NYSE:MON) has earned a consensus recommendation of “Hold” from the twenty-two ratings firms that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $122.24.

A number of equities research analysts have weighed in on MON shares. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Tuesday, June 27th. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Friday, June 16th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Tuesday, March 28th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, April 5th. Finally, Barclays PLC upped their price objective on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, June 29th.

COPYRIGHT VIOLATION WARNING: “Monsanto Company (MON) Receives Average Recommendation of “Hold” from Analysts” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/07/25/monsanto-company-mon-receives-average-recommendation-of-hold-from-analysts.html.

In related news, SVP Janet M. Holloway sold 3,337 shares of the stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $118.00, for a total transaction of $393,766.00. Following the completion of the transaction, the senior vice president now owns 44,405 shares in the company, valued at $5,239,790. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Kerry J. Preete sold 11,346 shares of the stock in a transaction dated Wednesday, May 3rd. The shares were sold at an average price of $116.86, for a total transaction of $1,325,893.56. Following the transaction, the executive vice president now owns 39,258 shares of the company’s stock, valued at approximately $4,587,689.88. The disclosure for this sale can be found here. In the last quarter, insiders sold 85,816 shares of company stock valued at $10,117,174. 0.79% of the stock is currently owned by corporate insiders.

Institutional investors have recently bought and sold shares of the stock. Raymond James Trust N.A. raised its position in Monsanto by 95.1% in the first quarter. Raymond James Trust N.A. now owns 7,533 shares of the basic materials company’s stock valued at $853,000 after buying an additional 3,671 shares during the last quarter. Paradigm Financial Advisors LLC raised its position in Monsanto by 40.6% in the first quarter. Paradigm Financial Advisors LLC now owns 11,965 shares of the basic materials company’s stock valued at $1,354,000 after buying an additional 3,456 shares during the last quarter. Acropolis Investment Management LLC raised its position in Monsanto by 6.9% in the first quarter. Acropolis Investment Management LLC now owns 3,110 shares of the basic materials company’s stock valued at $352,000 after buying an additional 201 shares during the last quarter. Chevy Chase Trust Holdings Inc. raised its position in Monsanto by 2.8% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 400,048 shares of the basic materials company’s stock valued at $45,286,000 after buying an additional 10,793 shares during the last quarter. Finally, Bridges Investment Counsel Inc. raised its position in Monsanto by 188.1% in the first quarter. Bridges Investment Counsel Inc. now owns 8,375 shares of the basic materials company’s stock valued at $948,000 after buying an additional 5,468 shares during the last quarter. Institutional investors own 74.96% of the company’s stock.

Shares of Monsanto (MON) opened at 117.50 on Tuesday. Monsanto has a 1-year low of $97.35 and a 1-year high of $118.97. The stock’s 50 day moving average is $117.59 and its 200 day moving average is $114.30. The company has a market capitalization of $51.62 billion, a PE ratio of 25.38 and a beta of 1.08.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. During the same period in the previous year, the firm posted $2.17 EPS. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, equities research analysts anticipate that Monsanto will post $4.89 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, July 7th will be issued a $0.54 dividend. The ex-dividend date is Wednesday, July 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. Monsanto’s dividend payout ratio is currently 46.75%.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.